MedTrace Logo

Treatment of Refractory Gout With ACTH or Methylprednisolone

NCT04808856 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-03-22

No results posted yet for this study

Summary

To clarify the therapeutic effect and safety evaluation of ACTH in refractory gouty arthritis and special population, and to explore its mechanism of action.

Conditions

Interventions

DRUG

Adrenocorticotropic Hormone

Adrenocorticotropic Hormone Injection 25u qd iv \*3d

DRUG

Methylprednisolone Injection

Methylprednisolone Injection 40mg qd iv \*3d

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Shen Qu, M.D Ph.D · Shanghai Tenth People' Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04808856 on ClinicalTrials.gov